Beryl Drugs Ltd
company logo

Beryl Drugs Ltd

Beryl Drugs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Start Investing in Beryl Drugs Ltd

*By signing up you agree to our Terms and Conditions

Beryl Drugs Ltd Performance

-

-

-

-


-

-

-

-

-

Beryl Drugs Ltd Fundamentals

18.79Cr

30.88

2.11

0.64

1.20

0%

17.55

i buttonClick here to know more about Fundamentals

Beryl Drugs Ltd Financials

Beryl Drugs Ltd Financialsright-arrow

Beryl Drugs Ltd Shareholding Pattern

Beryl Drugs Ltd Delivery and Volume

About Beryl Drugs Ltd

Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange. The Comp

-

1993

-

NameDesignation
Sanjay SethiED / MD / Promoter
Sudhir SethiChairman & Non Executive Dir.
Abhinav NaikIndependent Non Exe. Director
Shreya SarafIndependent Non Exe. Director
News and Events...

Similar Stocks

What's Trending

View All
View All

Beryl Drugs Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Beryl Drugs Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Beryl Drugs Ltd's share price is ₹36.48 as of 2024-09-19.
Beryl Drugs Ltd's P/E ratio is 30.88 times as of 2024-09-19.
Beryl Drugs Ltd's most recent financial reports indicate a price-to-book ratio of 2.11, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Beryl Drugs Ltd's market capitalization is ₹18.79 Cr as on 2024-09-19.
The current financial records of Beryl Drugs Ltd show a 10.03% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Beryl Drugs Ltd's most recent financial filings, the company has a total asset value of ₹10.73, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Beryl Drugs Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Beryl Drugs Ltd's 52-week high and low as of 2024-09-19 are ₹37.07 and ₹35.66, respectively.